Oramed Pharmaceuticals (NASDAQ:ORMP) Rating Increased to Buy at StockNews.com
Oramed Pharmaceuticals (NASDAQ:ORMP – Get Free Report) was upgraded by equities research analysts at StockNews.com from a “hold” rating to a “buy” rating in a report released on Wednesday. Separately, HC Wainwright reaffirmed a “neutral” rating on shares of Oramed Pharmaceuticals in a research report on Monday, September 9th. Read Our Latest Stock Analysis on […]
Intra-Cellular Therapies (NASDAQ:ITCI) Rating Reiterated by Cantor Fitzgerald
Cantor Fitzgerald reissued their overweight rating on shares of Intra-Cellular Therapies (NASDAQ:ITCI – Free Report) in a research note issued to investors on Monday, Benzinga reports. The firm currently has a $130.00 price objective on the biopharmaceutical company’s stock. Several other equities research analysts have also recently commented on the company. UBS Group decreased their […]
Cantor Fitzgerald Reaffirms Overweight Rating for Crinetics Pharmaceuticals (NASDAQ:CRNX)
Cantor Fitzgerald reissued their overweight rating on shares of Crinetics Pharmaceuticals (NASDAQ:CRNX – Free Report) in a research note issued to investors on Monday morning, Benzinga reports. They currently have a $90.00 price target on the stock. A number of other equities research analysts also recently weighed in on CRNX. Piper Sandler reaffirmed an overweight […]
UnitedHealth Group (NYSE:UNH) Receives “Overweight” Rating from Cantor Fitzgerald
Cantor Fitzgerald reiterated their overweight rating on shares of UnitedHealth Group (NYSE:UNH – Free Report) in a research note published on Monday morning, Benzinga reports. The firm currently has a $591.00 target price on the healthcare conglomerate’s stock. Several other research analysts have also recently weighed in on the company. Jefferies Financial Group upgraded UnitedHealth […]
TherapeuticsMD (NASDAQ:TXMD) Earns Hold Rating from Analysts at StockNews.com
StockNews.com initiated coverage on shares of TherapeuticsMD (NASDAQ:TXMD – Free Report) in a research report released on Monday morning. The brokerage issued a hold rating on the stock. TherapeuticsMD Stock Down 3.5 % TXMD stock opened at $1.66 on Monday. TherapeuticsMD has a fifty-two week low of $1.43 and a fifty-two week high of $3.42. […]
Origin Agritech (NASDAQ:SEED) Earns Hold Rating from Analysts at StockNews.com
StockNews.com started coverage on shares of Origin Agritech (NASDAQ:SEED – Free Report) in a research report released on Monday morning. The firm issued a hold rating on the biotechnology company’s stock. Origin Agritech Trading Down 0.4 % NASDAQ:SEED opened at $2.63 on Monday. Origin Agritech has a 1-year low of $1.37 and a 1-year high […]
Moleculin Biotech (NASDAQ:MBRX) Earns Sell Rating from Analysts at StockNews.com
StockNews.com started coverage on shares of Moleculin Biotech (NASDAQ:MBRX – Get Free Report) in a report released on Wednesday. The firm set a “sell” rating on the stock. Moleculin Biotech Stock Down 0.4 % Shares of MBRX stock opened at $2.46 on Wednesday. The firm’s 50-day moving average is $2.82 and its two-hundred day moving […]
Oncternal Therapeutics (NASDAQ:ONCT) Earns Hold Rating from Analysts at StockNews.com
StockNews.com initiated coverage on shares of Oncternal Therapeutics (NASDAQ:ONCT – Free Report) in a research report report published on Monday. The firm issued a hold rating on the stock. A number of other brokerages have also recently weighed in on ONCT. Northland Securities restated a market perform rating and issued a $2.00 price objective on […]
last updated on 21 Sep 00:45